Isoliensinine Augments the Therapeutic Potential of Paclitaxel in Multidrug-Resistant Colon Cancer Stem Cells and Induced Mitochondria-Mediated Cell Death

Researchers evaluated the chemo-sensitizing potential of the combinatorial regimen of isoliensinine (ISO) and Paclitaxcel on multidrug-resistant-HCT-15 cells to reduce the dose requirement of both ISO and Paclitaxcel.